It is known that diabetic patients and animal models of diabetes show reduced IGF-I levels that have been postulated as a possible cause of neurological disorders (Ishii, 1995; Busiguina et al., 1996; Guo et al., 1999; Ishii and Lupien, 2003). Here, IGF1 is linked to nervous system disorder.